Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer.

Hartl CA, Bertschi A, Puerto RB, Andresen C, Cheney EM, Mittendorf EA, Guerriero JL, Goldberg MS.

J Immunother Cancer. 2019 Jul 30;7(1):199. doi: 10.1186/s40425-019-0654-5.

2.

PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer.

Pantelidou C, Sonzogni O, De Oliveria Taveira M, Mehta AK, Kothari A, Wang D, Visal T, Li MK, Pinto J, Castrillon JA, Cheney EM, Bouwman P, Jonkers J, Rottenberg S, Guerriero JL, Wulf GM, Shapiro GI.

Cancer Discov. 2019 Jun;9(6):722-737. doi: 10.1158/2159-8290.CD-18-1218. Epub 2019 Apr 23.

PMID:
31015319
3.

Dysregulation in Actin Cytoskeletal Organization Drives Increased Stiffness and Migratory Persistence in Polyploidal Giant Cancer Cells.

Xuan B, Ghosh D, Cheney EM, Clifton EM, Dawson MR.

Sci Rep. 2018 Aug 9;8(1):11935. doi: 10.1038/s41598-018-29817-5.

4.

Aripiprazole-associated dyskinesia.

Sajbel TA, Cheney EM, DeQuardo JR.

Ann Pharmacother. 2005 Jan;39(1):200-1. Epub 2004 Dec 14. No abstract available.

PMID:
15598969
5.

Transient SIADH associated with fluoxetine.

Staab JP, Yerkes SA, Cheney EM, Clayton AH.

Am J Psychiatry. 1990 Nov;147(11):1569-70. No abstract available.

PMID:
2221175

Supplemental Content

Loading ...
Support Center